[go: up one dir, main page]

NO20053539L - New piperidine derivatives as modulators of chemokine receptor CCR5. - Google Patents

New piperidine derivatives as modulators of chemokine receptor CCR5.

Info

Publication number
NO20053539L
NO20053539L NO20053539A NO20053539A NO20053539L NO 20053539 L NO20053539 L NO 20053539L NO 20053539 A NO20053539 A NO 20053539A NO 20053539 A NO20053539 A NO 20053539A NO 20053539 L NO20053539 L NO 20053539L
Authority
NO
Norway
Prior art keywords
modulators
chemokine receptor
piperidine derivatives
receptor ccr5
new piperidine
Prior art date
Application number
NO20053539A
Other languages
Norwegian (no)
Other versions
NO20053539D0 (en
Inventor
Alan Faull
Howard Tucker
John Oldfield
John Graham Cumming
Colin Fielding
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0203821A external-priority patent/SE0203821D0/en
Priority claimed from SE0300499A external-priority patent/SE0300499D0/en
Priority claimed from PCT/SE2003/002008 external-priority patent/WO2004056773A1/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20053539D0 publication Critical patent/NO20053539D0/en
Publication of NO20053539L publication Critical patent/NO20053539L/en

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbindelser av formel (I): hvor R1, R2, R3, R4, A, X, m og n er som definert, preparater innbefattende slike forbindelser, fremgangsmåter for fremstilling av forbindelsene og deres anvendelse i medisinsk terapi (f.eks modulasjon av CCR5 reseptoraktivitet i varmblodige dyr).Compounds of formula (I): wherein R 1, R 2, R 3, R 4, A, X, m and n are as defined, compositions comprising such compounds, methods for the preparation of the compounds and their use in medical therapy (e.g. modulation of CCR5 receptor activity in warm-blooded animals).

NO20053539A 2002-12-20 2005-07-19 New piperidine derivatives as modulators of chemokine receptor CCR5. NO20053539L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0203821A SE0203821D0 (en) 2002-12-20 2002-12-20 Chemical Compounds
SE0300499A SE0300499D0 (en) 2003-02-24 2003-02-24 Chemical compounds
PCT/SE2003/002008 WO2004056773A1 (en) 2002-12-20 2003-12-18 Novel piperidine derivatives as modulators of chemokine receptor ccr5

Publications (2)

Publication Number Publication Date
NO20053539D0 NO20053539D0 (en) 2005-07-19
NO20053539L true NO20053539L (en) 2005-09-20

Family

ID=35295508

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053539A NO20053539L (en) 2002-12-20 2005-07-19 New piperidine derivatives as modulators of chemokine receptor CCR5.

Country Status (2)

Country Link
NO (1) NO20053539L (en)
RU (1) RU2005117343A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014018748A1 (en) * 2012-07-25 2014-01-30 Sarcode Bioscience Inc. Lfa-1 inhibitor and polymorph thereof

Also Published As

Publication number Publication date
RU2005117343A (en) 2006-01-27
NO20053539D0 (en) 2005-07-19

Similar Documents

Publication Publication Date Title
NO20062335L (en) New diazaspiroalkanes and their use in the treatment of CCR8 mediated diseases
NO20044826L (en) pyrrolidine
NO20045486L (en) New compounds and their use
SE9904652D0 (en) Novel Compounds
NO20055977L (en) New benzimidazole derivatives
NO20071137L (en) New piperidine derivatives for the treatment of depression
MY137144A (en) Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
NO20063355L (en) Novel tricyclic spiro derivatives as modulators of chemokine receptor activity
NO20054787L (en) Indene derivatives as pharmaceuticals
NO20065319L (en) Piperidine derivatives as modulators of chemokine receptor CCR5
NO20000722L (en) 2- (4-aryl or heteroaryl-piperazin-1-ylmethyl) -1H-indole derivatives
BR0317459A (en) New piperidine derivatives as chemokine ccr5 receptor modulators
NO20054135L (en) Kipolinone / benzoxazine derivatives and uses thereof
NO20062491L (en) Benzoxazine derivatives and their use
SE0203303D0 (en) Novel Compounds
WO2004056808A8 (en) Novel piperidine derivatives as modulators of chemokine receptor ccr5
WO2004056809A8 (en) Novel piperidine derivatives as modulators of chemokine receptor ccr5
NO20062900L (en) New connections
ATE521610T1 (en) SPIR COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
NO20063619L (en) Diarylmethylpiperazine derivatives, preparation and use thereof
NO20053539L (en) New piperidine derivatives as modulators of chemokine receptor CCR5.
MXPA05007483A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof.
TW200510312A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300104D0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
NO20055142L (en) Diarylmethylidene piperidine derivatives, preparations and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application